肌层浸润性膀胱癌保留膀胱治疗进展(3)
[13]曹达龙,叶定伟.免疫治疗在膀胱癌中的最新研究进展和未来展望[J].中国癌症杂志,2018,7(12):90-92.[14] Zhou T C,Sankin A I,Porcelli S A,et al.A review of the PD-1/PD-L1 checkpoint in bladder cancer:From mediator of immune escape to target for treatment11MPS is an investor in and consultant for Urogen.SAP is consultant and advisor for Vaccinex.The remaining authors have nothing to disclose[J].Urologic Oncology Seminars & Original Investigations ......
您现在查看是摘要页,全文长 2011 字符。